Pacira Pharmaceuticals, Inc. today announced results from EXCLAIM, its Phase 4 prospective, observational study to assess the use of EXPARELA for postsurgical analgesia in patients undergoing four common plastic surgery procedures.
http://www.biospace.com/news_story.aspx?StoryID=293208&full=1
http://www.biospace.com/news_story.aspx?StoryID=293208&full=1
No comments:
Post a Comment